← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2011Last known activity
Oct 15, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 5 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT04922138Lead sponsorPhase 2Oct 15, 2021
- NCT04270591Overall official - principal investigatorPhase 1/Phase 2Jul 15, 2019
- NCT03521154Overall official - principal investigatorPhase 3Jul 19, 2018
- NCT02148380Lead sponsorN/AMay 1, 2014
- NCT01217619Lead sponsorPhase 2Mar 1, 2011
Details
- Last known activity
- Oct 15, 2021